OPMEDIC GROUP announces the acquisition of the operations of Lab Cyto-Stat



    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
    DISSEMINATION IN THE UNITES STATES./

    MONTREAL, March 31 /CNW Telbec/ - OPMEDIC GROUP INC. ("OPMEDIC GROUP")
(TSX: OMG) is pleased to announce that it has completed the acquisition of the
operational assets of Lab Cyto-Stat, a Montréal laboratory specializing in
cytology and anatomic pathology.
    The acquisition of the assets of Lab Cyto-Stat will allow OPMEDIC GROUP,
to perform internally advanced cervico-vaginal cytology, human papilloma virus
and non gynaecological cytopathology testing that was up to now outsourced,
thereby increasing efficiency and higher profitability of its clinical
laboratory operations offered by its PROCREA Cliniques division. This
acquisition will also allow its PROCREA Cliniques division to offer current
Lab Cyto-Stat customers significantly more tests and accessible services since
PROCREA Cliniques division provides greater resources than were previously
available to them.
    "The new acquired cytology and anatomic pathology services will further
enhance our participation in our women's health initiative. This acquisition
demonstrates the continuous commitment of OPMEDIC GROUP to offer clients
quality and state of the art clinical laboratory services. Considering the
geographic location of OPMEDIC GROUP'S clinics and their territorial reach, we
will be in a position to manage efficiently our laboratory services offered
from our PROCREA Cliniques division and offer our services to new clientele",
said Dr. Pierre St-Michel, president and CEO of OPMEDIC GROUP.

    About OPMEDIC GROUP

    OPMEDIC GROUP is a company incorporated under the laws of the Province of
Quebec which provides healthcare-related services including surgical
facilities and services to patients and surgeons (with its OPMEDIC division),
fertility treatments, medical imaging, laboratory services and diagnostic
procedures (with its PROCREA Cliniques division) and sperm banking services
(with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common
Shares trade on the Toronto Stock Exchange under the symbol "OMG".

    This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offering would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

    The Content of this press release has not been approved by nor submitted
    to the TSX which assumes no liability therefore.




For further information:

For further information: Paulo BOUCA, Vice President, Business
Development and Chief Operating Officer, (514) 345-8535, x 2254,
pbouca@groupeopmedic.com

Organization Profile

Opmedic Group Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890